Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Critical limits for early detection of glaucoma, the Uppsala Glaucoma Detection Study (UGDS).

International ophthalmology·2026

Same author

Proteomic analysis of the aqueous humour in eyes with pseudoexfoliation syndrome.

The British journal of ophthalmology·2019

Same author

Variance components in confocal scanning laser tomography measurements of neuro-retinal rim area and the effect of repeated measurements on the power to detect loss over time.

Acta ophthalmologica·2016

Same author

Protein content in aqueous humor from patients with pseudoexfoliation (PEX) investigated by capillary LC MALDI-TOF/TOF MS.

Proteomics. Clinical applications·2015

Same author

Latanoprost in the treatment of glaucoma.

Clinical ophthalmology (Auckland, N.Z.)·2014

Same author

Proteins in aqueous humor from cataract patients with and without pseudoexfoliation syndrome.

European journal of mass spectrometry (Chichester, England)·2013

Search research articles

Related Experiment Videos

Uveoscleral outflow--a review.

Albert Alm¹, Siv F E Nilsson

¹Department of Neuroscience, Ophthalmology, University Hospital, University of Uppsala, Uppsala, Sweden. albert.alm@akademiska.se

Experimental Eye Research

|January 20, 2009

Summary

The uveoscleral outflow pathway facilitates aqueous humor drainage from the eye. Medications like prostaglandins enhance this route, aiding glaucoma treatment despite limited understanding of its full physiological role.

Area of Science:

Ophthalmology
Ocular Physiology
Glaucoma Research

Background:

The uveoscleral outflow pathway, described over 40 years ago, accounts for significant aqueous humor drainage in non-human primates (40-50%).
Human studies suggest a similar fraction, particularly in younger individuals, though age-dependent reductions may exist.
Unlike trabecular outflow, uveoscleral flow is minimally affected by normal intraocular pressure (IOP) ranges.

Purpose of the Study:

To review the physiological role and clinical significance of the uveoscleral outflow pathway.
To discuss factors influencing uveoscleral flow, including ciliary muscle state and pharmacological agents.
To highlight the therapeutic potential of modulating uveoscleral outflow for managing intraocular pressure.

Main Methods:

Related Experiment Videos

Review of existing literature on uveoscleral outflow mechanisms.
Analysis of species differences in aqueous humor drainage routes.
Examination of the effects of ciliary muscle contraction/relaxation and pharmacological agents on uveoscleral flow.

Main Results:

Ciliary muscle state is critical: contraction reduces, relaxation increases uveoscleral flow.
Cholinergic agents and epinephrine (via beta(2)-adrenergic receptors) influence uveoscleral outflow.
Prostaglandin F(2alpha) and its analogues increase uveoscleral flow by altering ciliary muscle extracellular matrix, effectively reducing IOP.

Conclusions:

Modulating uveoscleral outflow is a valuable strategy for glaucoma treatment.
The uveoscleral pathway serves as an important route for aqueous and protein drainage during intraocular inflammation.
Despite therapeutic successes, the precise physiological role of uveoscleral flow remains incompletely understood.